Patents by Inventor Markus Bergauer

Markus Bergauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8153681
    Abstract: The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, useful in the treatment of diseases and conditions mediated by modulation of use-dependent voltage-gated sodium channels. Methods of treating epilepsy in a mammal are also provided.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: April 10, 2012
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: Giuseppe Alvaro, Markus Bergauer, Roberto Profeta, Riccardo Giovannini
  • Patent number: 8153623
    Abstract: Compounds of formula (I), pharmaceutical compositions thereof, and methods for treatment using the same.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: April 10, 2012
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: Giuseppe Alvaro, David Amantini, Markus Bergauer, Francesca Bonetti, Roberto Profeta
  • Patent number: 8143306
    Abstract: The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, useful in the treatment of diseases and conditions mediated by modulation of use-dependent voltage-gated sodium channels. Methods of treating and moderating one or more bipolar disorders in a mammal are also provided.
    Type: Grant
    Filed: January 4, 2011
    Date of Patent: March 27, 2012
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: Giuseppe Alvaro, Markus Bergauer, Roberto Profeta, Riccardo Giovannini
  • Publication number: 20120022056
    Abstract: Compounds of formula (I) wherein R1, R2, X, A, Y, B, Z1, Q, p, r and s are defined in the specification for treating inter alia psychotic disorders, depressive disorders, anxiety disorders and sexual dysfunctions.
    Type: Application
    Filed: August 29, 2005
    Publication date: January 26, 2012
    Inventors: Jonathan Bentley, Markus Bergauer, Babara Bertani, Matteo Biagetti, Manuela Borriello, Steven Mark Bromidge, Massimo Gianotti, Enrica Granci, Colin Philip Leslie, Alessandra Pasquarello, Valeria Zucchelli
  • Publication number: 20110098335
    Abstract: The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, useful in the treatment of diseases and conditions mediated by modulation of use-dependent voltage-gated sodium channels.
    Type: Application
    Filed: January 4, 2011
    Publication date: April 28, 2011
    Applicant: Convergence Pharmaceuticals Limited
    Inventors: Giuseppe Alvaro, Markus Bergauer, Roberto Profeta, Riccardo Giovannini
  • Publication number: 20100324022
    Abstract: Compounds of formula (I), pharmaceutical compositions thereof, and methods for treatment using the same.
    Type: Application
    Filed: August 4, 2010
    Publication date: December 23, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Giuseppe Alvaro, David Amantini, Markus Bergauer, Francesca Bonetti, Roberto Profeta
  • Patent number: 7855218
    Abstract: Compounds of formula (I) wherein the variables are defined herein, pharmaceutical compositions thereof and methods for treatment using the same.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: December 21, 2010
    Assignee: Convergence Pharmaceuticals Limited
    Inventors: Giuseppe Alvaro, Daniele Andreotti, Markus Bergauer, Riccardo Giovannini, Agostino Marasco
  • Patent number: 7803833
    Abstract: The invention relates to quaternary ?-aminocarboxyamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, X, q and n are as defined in claim 1, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: September 28, 2010
    Assignee: Glaxo Group Limited
    Inventors: Giuseppe Alvaro, David Amantini, Markus Bergauer, Francesca Bonetti, Roberto Profeta
  • Publication number: 20100204273
    Abstract: Disclosed are methods for use of compounds of formula (I) in the treatment of CNS disorders such as dysthymia, schizophrenia, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, pain, and memory disorders: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok, Keong Vong, Simon Edward Ward
  • Patent number: 7732600
    Abstract: Disclosed are methods for the preparation of compounds of formula (I): wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: June 8, 2010
    Assignee: Glaxo Group Limited
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok Keong Vong, Simon Edward Ward
  • Publication number: 20100130583
    Abstract: The invention relates to quaternary ?-aminocarboxyamide derivatives of formula (I) and their pharmaceutically salts or solvates wherein R1 is H or CH3; and R2 is H or CH3, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels.
    Type: Application
    Filed: April 1, 2008
    Publication date: May 27, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Giuseppe Alvaro, Markus Bergauer, Agostino Marasco
  • Publication number: 20100105754
    Abstract: The invention provides a compound of formula (I), a solvate, a salt or prodrug thereof, useful in the treatment of diseases and conditions mediated by modulation of use-dependent voltage-gated sodium channels.
    Type: Application
    Filed: December 17, 2009
    Publication date: April 29, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Giuseppe Alvaro, Markus Bergauer, Roberto Profeta, Riccardo Giovannini
  • Patent number: 7655693
    Abstract: The invention provides a compound of formula (I), pharmaceutical compositions thereof, and methods of treatment using the same.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: February 2, 2010
    Assignee: Glaxo Group Limited
    Inventors: Giuseppe Alvaro, Markus Bergauer, Roberto Profeta, Riccardo Giovannini
  • Publication number: 20090312546
    Abstract: Disclosed are methods for the preparation of compounds of formula (I): wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Application
    Filed: August 13, 2009
    Publication date: December 17, 2009
    Inventors: Markus BERGAUER, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok, Keong Vong, Simon Edward Ward
  • Patent number: 7592346
    Abstract: Disclosed are methods for use of compounds of formula (I) in combination with other active substances in the treatment of CNS disorders such as depression or anxiety. wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: September 22, 2009
    Assignee: Glaxo Group Limited
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok Keong Vong, Simon Edward Ward
  • Publication number: 20080306122
    Abstract: Compounds of formula (I) wherein the variables are defined herein, pharmaceutical compositions thereof and methods for treatment using the same.
    Type: Application
    Filed: October 6, 2006
    Publication date: December 11, 2008
    Inventors: Giuseppe Alvaro, Daniele Andreotti, Markus Bergauer, Riccardo Giovannini, Agostino Marasco
  • Publication number: 20080293753
    Abstract: The invention relates to quaternary ?-aminocarboxyamide derivatives of formula (I), wherein R1, R2, R3, R4, R5, R6, X, q and n are as defined in claim 1, for treating diseases and conditions mediated by modulation of voltage-gated sodium channels.
    Type: Application
    Filed: October 6, 2006
    Publication date: November 27, 2008
    Inventors: Giuseppe Alvaro, David Amantini, Markus Bergauer, Francesca Bonetti, Roberto Profeta
  • Publication number: 20080280969
    Abstract: The invention provides a compound of formula (I), pharmaceutical compositions thereof, and methods of treatment using the same.
    Type: Application
    Filed: October 6, 2006
    Publication date: November 13, 2008
    Inventors: Giuseppe Alvaro, Markus Bergauer, Roberto Profeta, Riccardo Giovannini
  • Publication number: 20080280919
    Abstract: Disclosed are methods for use of compounds of formula (I) in combination with other active substances in the treatment of CNS disorders such as depression or anxiety. wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description.
    Type: Application
    Filed: July 2, 2008
    Publication date: November 13, 2008
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Mark Bromidge, Alessandro Falchi, Colin Philip Leslie, Giancarlo Merlo, Domenica Antonia Pizzi, Marilisa Rinaldi, Luigi Piero Stasi, Jessica Tibasco, Antonio Kuok Keong Vong, Simon Edward Ward
  • Publication number: 20070167423
    Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.
    Type: Application
    Filed: March 16, 2007
    Publication date: July 19, 2007
    Inventors: Markus Bergauer, Barbara Bertani, Matteo Biagetti, Steven Bromidge, Alessandro Falchi, Colin Leslie, Giancarlo Merlo, Domenica Pizzi, Marilisa Rinaldi, Luigi Stasi, Jessica Tibasco, Antonio Vong, Simon Ward